Inventor
FOWLER KERRY W
US43 patents
⚠️ This page may combine multiple inventors who share the name “FOWLER KERRY W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ICOS CORP
27 patentsUS7932260B2Apr 26, 2011
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP221 citations99
US8980901B2Mar 17, 2015
5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP39 citations98
US8586597B2Nov 19, 2013
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP36 citations98
USRE44599ENov 12, 2013
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP44 citations98
US8993583B2Mar 31, 2015
5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP22 citations96
US8779131B2Jul 15, 2014
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP30 citations96
US6348602B1Feb 19, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP49 citations96
US6423710B1Jul 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP47 citations95
US6258833B1Jul 10, 2001
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP55 citations94
US9149477B2Oct 6, 2015
5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP17 citations92
US6716871B2Apr 6, 2004
Cyclic AMP-specific phosphodie sterase inhibitors
ICOS CORP14 citations92
US6680336B2Jan 20, 2004
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP23 citations92
US6500856B2Dec 31, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP20 citations92
US6486186B2Nov 26, 2002
Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
ICOS CORP43 citations92
US6455562B1Sep 24, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP18 citations92
US6376489B1Apr 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP22 citations92
US6313156B1Nov 6, 2001
Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
ICOS CORP20 citations92
US6294561B1Sep 25, 2001
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP22 citations92
US6569885B1May 27, 2003
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP18 citations91
US6569890B2May 27, 2003
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP19 citations91
US6458787B1Oct 1, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP24 citations91
US6372777B1Apr 16, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP36 citations91
US10336756B2Jul 2, 2019
(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP5 citations84
US10906907B2Feb 2, 2021
Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
ICOS CORP0 citations73
US6998416B2Feb 14, 2006
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP1 citations62
US7176229B2Feb 13, 2007
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP0 citations51
US7087634B2Aug 8, 2006
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP0 citations51
SEARLE & CO
8 patentsUS4704382ANov 3, 1987
Phenylpiperazine phosphonates
SEARLE & CO44 citations92
US5098915AMar 24, 1992
Substituted N-benzylpiperidine amides
SEARLE & CO20 citations74
US5247119ASep 21, 1993
Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
SEARLE & CO10 citations73
US5028616AJul 2, 1991
N-benzylpiperidine amides
SEARLE & CO18 citations73
US4628095ADec 9, 1986
Substituted N-benzyl-4-(benzhydryl) piperidines
SEARLE & CO13 citations73
US5070094ADec 3, 1991
N-benzyltropaneamides
SEARLE & CO5 citations63
US4680295AJul 14, 1987
Octahydropyrido[1,2-c]pyrimidinones and hexahydropyrido[1,2-c]pyrimidinediones
SEARLE & CO4 citations63
US4992446AFeb 12, 1991
Tricyclic quinolizine amides
SEARLE & CO1 citations52
KINETA INC
4 patentsUS9884876B2Feb 6, 2018
Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
KINETA INC21 citations87
US9073946B2Jul 7, 2015
Anti-viral compounds
KINETA INC3 citations53
US9555106B2Jan 31, 2017
Anti-viral compounds
KINETA INC0 citations46
US9956285B2May 1, 2018
Anti-viral compounds
KINETA INC0 citations45